136 related articles for article (PubMed ID: 30695776)
1. Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling.
Ding Z; Shi H; Yang W
Pharmacology; 2019; 103(3-4):163-172. PubMed ID: 30695776
[TBL] [Abstract][Full Text] [Related]
2. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.
Hou JM; Xue Y; Lin QM
Acta Pharmacol Sin; 2012 Oct; 33(10):1277-84. PubMed ID: 22902986
[TBL] [Abstract][Full Text] [Related]
3. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.
Li G; Bu J; Zhu Y; Xiao X; Liang Z; Zhang R
Int J Clin Exp Pathol; 2015; 8(12):15684-95. PubMed ID: 26884838
[TBL] [Abstract][Full Text] [Related]
4. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
5. Thyrotoxicosis Involves β2-Adrenoceptor Signaling to Negatively Affect Microarchitecture and Biomechanical Properties of the Femur.
Neofiti-Papi B; Albuquerque RP; Miranda-Rodrigues M; Gonçalves NJN; Jorgetti V; Brum PC; Ferreira JCB; Gouveia CHA
Thyroid; 2019 Aug; 29(8):1060-1072. PubMed ID: 31264512
[No Abstract] [Full Text] [Related]
6. Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis.
Liu WJ; Jiang ZM; Chen Y; Xiao PT; Wang ZY; Huang TQ; Liu EH
J Ethnopharmacol; 2020 Jul; 257():112871. PubMed ID: 32325182
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro action mechanism of treatment of glucocorticoid-induced osteoporosis by regulation of osteoprotegerin/receptor activator of nuclear factor-κB pathways by denshensu.
Li J
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):67-74. PubMed ID: 37953581
[TBL] [Abstract][Full Text] [Related]
8. Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats.
Liu C; Wang L; Zhu R; Liu H; Ma R; Chen B; Li L; Guo Y; Jia Q; Shi S; Zhao D; Mo F; Zhao B; Niu J; Fu M; Orekhov AN; Brömme D; Gao S; Zhang D
Osteoporos Int; 2019 Feb; 30(2):491-505. PubMed ID: 30151623
[TBL] [Abstract][Full Text] [Related]
9. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway.
Zhao Y; Wang HL; Li TT; Yang F; Tzeng CM
Drug Des Devel Ther; 2020; 14():195-206. PubMed ID: 32021104
[TBL] [Abstract][Full Text] [Related]
10. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
[TBL] [Abstract][Full Text] [Related]
11. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
Wang J; Wang K; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
[TBL] [Abstract][Full Text] [Related]
12. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
Liu W; Zhang X
Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
[TBL] [Abstract][Full Text] [Related]
13. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
Lu J; Liu F; Liu D; Du H; Hao J; Yang X; Cui W
Exp Biol Med (Maywood); 2016 Jun; 241(11):1237-49. PubMed ID: 26908571
[TBL] [Abstract][Full Text] [Related]
14. Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity.
Staines KA; Hopkinson M; Dillon S; Stephen LA; Fleming R; Sophocleous A; Buttle DJ; Pitsillides AA; Farquharson C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894854
[TBL] [Abstract][Full Text] [Related]
15. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling.
Jiang Y; Zhang Y; Chen W; Liu C; Li X; Sun D; Liu Z; Xu Y; Mao X; Guo Q; Lin N
J Transl Med; 2014 Nov; 12():334. PubMed ID: 25471933
[TBL] [Abstract][Full Text] [Related]
16. Receptor Activator of Nuclear Factor κ-Β Ligand/Osteoprotegerin Axis in Adults with Hb S/β-Thalassemia and β-Thalassemia Trait.
Tombak A; Boztepe B; Akbayir S; Dogru G; Sungur MA
Hemoglobin; 2020 Sep; 44(5):334-337. PubMed ID: 32873083
[TBL] [Abstract][Full Text] [Related]
17. The wakefulness promoting drug Modafinil causes adenosine receptor-mediated upregulation of receptor activator of nuclear factor κB ligand in osteoblasts: Negative impact of the drug on peak bone accrual in rats.
Pal China S; Pal S; Chattopadhyay S; Porwal K; Mittal M; Sanyal S; Chattopadhyay N
Toxicol Appl Pharmacol; 2018 Jun; 348():22-31. PubMed ID: 29649498
[TBL] [Abstract][Full Text] [Related]
18. Alginate oligosaccharide alleviates senile osteoporosis via the RANKL-RANK pathway in D-galactose-induced C57BL/6J mice.
Wang S; Feng W; Liu J; Wang X; Zhong L; Lv C; Feng M; An N; Mao Y
Chem Biol Drug Des; 2022 Jan; 99(1):46-55. PubMed ID: 34145772
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression.
Zhang Y; Liu MW; He Y; Deng N; Chen Y; Huang J; Xie W
Int J Immunopathol Pharmacol; 2020; 34():2058738420941762. PubMed ID: 32674689
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.
Peng WX; Ye C; Dong WT; Yang LL; Wang CQ; Wei ZA; Wu JH; Li Q; Deng J; Zhang J
Exp Biol Med (Maywood); 2017 Jun; 242(12):1234-1243. PubMed ID: 28454497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
